STU3 Candidate

This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3

4.3.2.19377 HL7 v3 Value Set SubstanceAdminSubstitutionReason

This value set (http://hl7.org/fhir/ValueSet/v3-SubstanceAdminSubstitutionReason) is defined as part of HL7 v3. Related FHIR content: SubstanceAdminSubstitutionReason.

Summary

Defining URL:http://hl7.org/fhir/ValueSet/v3-SubstanceAdminSubstitutionReason
Name:SubstanceAdminSubstitutionReason
Definition:No Description Provided
OID:2.16.840.1.113883.1.11.19377 (for OID based terminology systems)
Source ResourceXML / JSON

This value set is used in the following places:

4.3.2.19377.1 Content Logical Definition

This value set includes codes from the following code systems:

 

4.3.2.19377.2 Expansion

This expansion generated 06 Dec 2016

This value set contains 4 concepts

Expansion based on http://hl7.org/fhir/v3/ActReason version 2016-11-11

All codes from system http://hl7.org/fhir/v3/ActReason

CodeDisplayDefinition
CTcontinuing therapyIndicates that the decision to substitute or to not substitute was driven by a desire to maintain consistency with a pre-existing therapy. I.e. The performer provided the same item/service as had been previously provided rather than providing exactly what was ordered, or rather than substituting with a lower-cost equivalent.
FPformulary policyIndicates that the decision to substitute or to not substitute was driven by a policy expressed within the formulary.
OSout of stockIn the case of 'substitution', indicates that the substitution occurred because the ordered item was not in stock. In the case of 'no substitution', indicates that a cheaper equivalent was not substituted because it was not in stock.
RRregulatory requirementIndicates that the decision to substitute or to not substitute was driven by a jurisdictional regulatory requirement mandating or prohibiting substitution.